Latest Nordion Inc (NDZ) Headlines Hill-Rom Ele
Post# of 3
Posted On: 03/14/2014 6:15:21 AM
Latest Nordion Inc (NDZ) Headlines
Hill-Rom Elects William G. Dempsey to its Board of Directors
PR Newswire - Mon Mar 10, 7:00AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that William G. Dempsey has been elected to its Board of Directors. He currently serves as a director of Landauer, Inc., Nordion Inc., and Hospira, Inc., and previously held various executive positions with Abbott Laboratories, including Executive Vice President of Global Pharmaceuticals, Senior Vice President of Pharmaceutical Operations, and Senior Vice President of International Operations. He also previously served as Chairman of the International Section of the Pharmaceutical Research and Manufacturers of America (PhRMA) and as Chairman of the Accelerating Access Initiative, a cooperative public-private partnership of UNAIDS, the World Bank, and six research-based pharmaceutical companies.
Nordion jumps up to GAAP net income of USD35.3m in Q1 fiscal 2014
M2 - Mon Mar 10, 5:00AM CDT
Health service company Nordion (TSX:NDN.TO) (NYSE:NDZ) announced on Friday its GAAP net income of USD35.3m for the first quarter of fiscal 2014.
Nordion Reports First Quarter Fiscal 2014 Financial Results
Business Wire - Fri Mar 07, 6:00AM CST
--GAAP earnings per share (EPS) of $0.57 in Q1 2014 versus $nil in Q1 2013. Non-GAAP adjusted EPS of $0.59 in Q1 2014, up from non-GAAP adjusted EPS of $0.05 in Q1 2013
Sterilization Equipment and Disinfectants Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Fri Mar 07, 3:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/z899cm/sterilization) has announced the addition of the "Sterilization Equipment and Disinfectants Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering 'Sterilization Equipment and Disinfectants Market (By Sterilization Equipment Type - Heat Sterilization, Low Temperature Sterilization, Filtration Sterilization and Radiation Sterilization,By Disinfectants Type-Low, Intermediate and High level and Oxidizing and Non-Oxidizing and By Applications- Medical Devices, Pharmaceuticals and Life-Sciences) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019' "Sterilization equipment and disinfectants are essential procedures for infection control in healthcare facilities such as hospitals, clinics and laboratories. Increase in hospital acquired infections has compelled medical professionals to take strict regulatory actions to cure these infections with the use of various sterilization equipment and disinfectants. This factor will trigger the growth of sterilization equipment and disinfectants market during the forecast period. In addition, rise in geriatric population and increase in the number of surgeries performed at hospitals and clinics will further drive the growth of this market. The market for sterilization equipment can be segmented as: by product (heat, low temperature, radiation and filtration sterilization) and by application (life sciences, medical devices and pharmaceuticals). The disinfectants market has been segmented based on types (low, intermediate and high level, oxidizing and non-oxidizing disinfectants). The report includes market estimations in terms of revenue (USD million) for the global sterilization equipment and disinfectants market for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for all the aforementioned segments and sub segments. In addition, current market trends and recent developments have been taken into consideration while determining the growth rate of the global sterilization equipment and disinfectants market. Key Topics Covered: Introduction Executive Summary Market Overview Global Sterilization Equipment Market, By Product, 2011 - 2019 (USD Million) Global Disinfectants Market, By Type, 2011 - 2019 (USD Million) Global Sterilization Equipment and Disinfectants Market, By Applications, 2011 - 2019 (USD Million) Global Sterilization Equipment and Disinfectants Market, by Geography, 2011 - 2019 (USD Million) Recommendations Company Profiles Companies Mentioned - 3M - Advanced Sterilization Products Services, Inc. - Belimed AG - Cantel Medical Corp. - CISA Group - Getinge Group - Kimberley-Clark Corporation - Matachana Group - Nordion, Inc. - SAKURA SI CO., LTD. - STERIS Corporation - Synergy Health Plc - TSO3, Inc. For more information visit http://www.researchandmarkets.com/research/z8...rilization About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Nordion Signs Two-Year Strontium-82 Supply Contract with Bracco Diagnostics
Business Wire - Tue Mar 04, 7:01AM CST
Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced today that it has entered into a two-year contract with Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leading company in the diagnostic imaging business, to supply strontium-82, a cyclotron based medical isotope produced both at Nordion's Vancouver, British Columbia and Ottawa, Ontario facilities.
Nordion to Release First Quarter Fiscal 2014 Financial Results
Business Wire - Fri Feb 28, 11:00AM CST
Nordion Inc. (TSX:NDN; NYSE:NDZ), a leading provider of products and services to the global health science market, today announced that the Company is scheduled to report its first quarter fiscal 2014 financial results before markets open on March 7, 2014.
North American Radiopharmaceuticals Market is Poised to Reach $2.7 Billion By 2017 at a CAGR of 7.2%
M2 - Wed Feb 26, 10:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/5r3ppz/north_american) has announced the addition of the "North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - Forecast to 2017" report to their offering. A study conducted by Organization for Economic Co-operation and Development (OECD) estimates that Tc-99m diagnostic procedures are expected to increase by 15% to 20% in mature markets such as North America between 2010 and 2030. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinson's disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications. The scheduled shutdown of the NRU reactor in 2016 in Canada is, however, a major threat for manufacturers. The U.S. is the dominant market for diagnostic radioisotopes with more than 80% share. The U.S. is the largest consumer market for radiopharmaceuticals in North America, while Canada is one of the largest producers of Tc-99m. Major players in the radiopharmaceuticals market are Cardinal Health, Inc. (U.S.), Lantheus Medical Imaging, Inc. (U.S.), Nordion, Inc. (Canada), and Triad Isotopes, Inc. (U.S.). The stable isotopes market was led by two players - Cambridge Isotope Laboratories (CIL) and Sigma Aldrich - in 2012; they jointly contributed more than 90% to the North American revenue. Companies Mentioned: - Australian Nuclear Association And Technology Organization (Ansto) - Board Of Radiation And Isotope Technology (Brit) - Bracco Imaging S.P.A. - Cambridge Isotope Laboratories, Inc. - Cardinal Health, Inc. - Covidien, Plc - Eczacibasi-Monrol - Fujifilm Holdings Corporation - Ge Healthcare (Subsidiary Of General Electric Company) - Iba Group - Institute Of Atomic Energy Polatom Radioisotope Centre - Institute Of Isotopes Co., Ltd. - Institute Of Radioelement (Ire) - Isotec, Inc. (Sigma-Aldrich) - Lantheus Medical Imaging, Inc. - Nordion, Inc. - Ntp Radioisotopes (Pty), Ltd. - Petnet Solutions, Inc. (A Subsidiary Of Siemens Medical Solutions Usa, Inc.) - Rotem Industries, Ltd., Inc. - Taiyo Nippon Sanso Corporation - Triad Isotopes, Inc. - Urenco Limited For more information visit http://www.researchandmarkets.com/research/5r...h_american About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Rubber Market 2014-2018 with Styron LLC, Thai Rubber Latex Corp., and The DOW Chemical Co. Dominating
M2 - Wed Feb 19, 11:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/938d94/global_rubber) has announced the addition of the "Global Rubber Market 2014-2018" report to their offering. The analysts forecast the Global Rubber market to grow at a CAGR of 5.89 percent and 6.36 percent on the basis of production and consumption, respectively, over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand for disposable medical gloves. The Global Rubber market has also been witnessing the increasing demand for synthetic rubber from the emerging economies. However, the increasing demand of natural disasters and adverse weather conditions could pose a challenge to the growth of this market. Key vendors dominating this space are BASF SE, Styron LLC, Thai Rubber Latex Corp., and The DOW Chemical Co. Other vendors mentioned in the report are Advance Multitech Ltd., Advance Petrochemical Ltd., Ansell Ltd., Asahi Kasei Corp., Bando Chemical Industries Ltd., Bridgestone Corp., Behn Meyer Group, China National Petroleum Corp., Convex Latex Pvt. Ltd., HLL Lifecare Ltd., Hwafong Rubber Thailand Public Co. Ltd., Lanxess AG, LG Chem Ltd., Nishikawa Rubber Co. Ltd., Nordion Inc., RFB Rubber Ltd., Shun Thai Rubber Gloves Industry Public Co. Ltd., Sinopec Ltd., Sumitomo Chemical Co. Ltd., St. Marys Rubbers Pvt. Ltd., Synthos S.A., Textile Rubber & Chemical Co. Inc., Tianjin Lugang Petroleum Rubber Co. Ltd., Versalis S.p.A, and Wacker Chemie AG. Commenting on the report, an analyst from the team said: The demand for synthetic rubber is estimated to increase at a steady pace in the future due to the growing demand from emerging economies. The APAC region is the largest synthetic rubber consumer, with China being the leader in synthetic rubber production and consumption. The rubber market in the APAC region is expected to grow at a rapid pace during the forecast period. It is expected to account for more than 50 percent of the production and consumption of synthetic rubber with the increasing demand for synthetic rubber in the Automobile sector, and the Construction and Tire industries. For more information visit http://www.researchandmarkets.com/research/93...bal_rubber About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Concise Analysis of the International Radiopharmaceuticals Market
M2 - Fri Feb 14, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/5ltj8g/radiopharmaceutica) has announced the addition of the "Concise Analysis of the International Radiopharmaceuticals Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: - Diagnostic Radiopharmaceuticals - Therapeutic Radiopharmaceuticals. The report profiles 69 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc. - Advanced Medical Isotope Corporation - Alseres Pharmaceuticals Inc. - Bayer HealthCare Pharmaceuticals - Bracco Diagnostics Inc. - Cardinal Health Inc. - Covidien Plc - Eli Lilly and Company - Erigal Limited - EUSA Pharma (Europe) Ltd. - GE Healthcare - IBA Group - Immunomedics Inc. - Jubilant Life Sciences Limited - Lantheus Medical Imaging Inc. - Medi-Radiopharma Ltd. - Nordion Inc. - Peregrine Pharmaceuticals Inc. - PETNET Solutions Inc. - Positron Corporation - Singapore Radiopharmaceuticals Pte Ltd. - Triad Isotopes Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers & Trends 3. Market Challenges 4. Therapeutic Radiopharmaceutical Products Under Development 5. Imaging Agents - An Overview 6. Nuclear Medicine - An Overview 7. Product Overview 8. Product Innovations/Introductions 9. Product Innovations/Introductions In Recent Past- A Perspective Builder 10. Recent Industry Activity 11. Corporate Activity In The Recent Past - A Perspective Builder 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79) - The United States (36) - Canada (2) - Japan (1) - Europe (28) - France (2) - Germany (2) - The United Kingdom (4) - Italy (2) - Spain (1) - Rest of Europe (17) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/5l...rmaceutica
2014 Report on the European Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017
M2 - Mon Jan 27, 4:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/gchtqj/european_nuclear) has announced the addition of the "2014 Report on the European Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017" report to their offering. The therapy market is predominantly driven by its oncologic applications. Since conventional treatment procedures of cancer, surgery and chemotherapy have significant side effects, radioisotopes are being preferred by medical practitioners due to minimum or no side effects. The radiopharmaceutical therapy market is expected to grow significantly with the launch of the much-desired Alpharadin (Ra-223) in the near future. This isotope has tremendous potential to take up market share of beta emitters and brachytherapy. Germany accounted for the largest market share of the European nuclear medicine market, followed by France in 2012. Major players in the radiopharmaceuticals market are Covidien, Plc, GE Healthcare, IBA Group, Lantheus Medical Imaging, Inc., Nordion, Inc., and Siemens Healthcare (PETNET). The stable isotopes market is dominated by deuterium (D2), oxygen-18 (O-18), carbon-13 (C-13), and nitrogen-15 (N-15). It has major applications in research, pharmaceuticals, diagnostic and therapy, and the industrial sector. The diagnostic and therapy market accounted for the maximum share of the stable isotopes market. The European stable isotopes market was valued at close to $25.0 million in 2012, and is estimated to grow at a CAGR of more than 8.0% by 2017. The stable isotopes market was led by two players - Cambridge Isotope Laboratories (CIL) and Sigma Aldrich - in 2012; they jointly contributed more than 50% to the European revenue. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 European Radiopharmaceuticals Market, By Isotope 5 European Radiopharmaceuticals Market,By Application/Indication 6 European Enriched Stable Isotopes Market 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles Companies Mentioned: - Bracco Imaging - Cambridge Isotope Laboratories - Cardinal Health - Covidien - Eczacibasi-Monrol - Fujifilm Holdings - GE Healthcare - IBA Group - Isotec - Lantheus Medical Imaging - NTP Radioisotopes - Nordion, Inc - Petnet Solutions - Rotem Industries - Taiyo Nippon Sanso - Urenco For more information visit http://www.researchandmarkets.com/research/gc...an_nuclear
Why Macy's, Nordion, and Acuity Brands Soared Today
Dan Caplinger, The Motley Fool - Motley Fool - Thu Jan 09, 7:01PM CST
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis. The stock market fought mostly to a draw on Thursday, with...
NYSE stocks posting largest percentage increases
AP - Thu Jan 09, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
Nordion Reports Fourth Quarter and Fiscal 2013 Financial Results; Provides Fiscal 2014 Outlook
Business Wire - Thu Jan 09, 5:59AM CST
--GAAP earnings per share (EPS) of $0.91 in Q4 2013 versus $0.70 loss per share (LPS) in Q4 2012. Adjusted EPS, excluding specified items, of $0.15 in Q4 2013, down from adjusted EPS of $0.27 in Q4 2012
2013 Report on the North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017
M2 - Mon Dec 23, 3:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/gn9bsn/north_american) has announced the addition of the "2013 Report on the North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017" report to their offering. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinson's disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications. The scheduled shutdown of the NRU reactor in 2016 in Canada is, however, a major threat for manufacturers. The therapy market is predominantly driven by its oncologic applications. Since conventional treatment procedures of cancer, surgery and chemotherapy have significant side effects; radioisotopes are being preferred by medical practitioners due to minimum or no side effects. The radiopharmaceutical therapy market is expected to grow significantly with the launch of the much-desired Alpharadin (Ra-223) in the near future. This isotope has tremendous potential to take up market share of beta emitters and brachytherapy. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 North American Radiopharmaceuticals Market, By Isotope 5 North American Radiopharmaceuticals Market, By Application/Indications 6 North American Enriched Stable Isotopes Market 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles Companies Mentioned: - Australian Nuclear Association And Technology Organization (Ansto) - Board Of Radiation And Isotope Technology (Brit) - Bracco Imaging S.P.A. - Cambridge Isotope Laboratories, Inc. - Cardinal Health, Inc. - Covidien, Plc - Eczacibasi-Monrol - Fujifilm Holdings Corporation - Ge Healthcare (Subsidiary Of General Electric Company) - Iba Group - Institute Of Atomic Energy Polatom Radioisotope Centre - Institute Of Isotopes Co., Ltd. - Institute Of Radioelement (Ire) - Isotec, Inc. (Sigma-Aldrich) - Lantheus Medical Imaging, Inc. - Nordion, Inc. - Ntp Radioisotopes (Pty), Ltd. - Petnet Solutions, Inc. (A Subsidiary Of Siemens Medical Solutions Usa, Inc.) - Rotem Industries, Ltd., Inc. - Taiyo Nippon Sanso Corporation - Triad Isotopes, Inc. - Urenco Limited For more information visit http://www.researchandmarkets.com/research/gn...h_american
Nordion to Release Fourth Quarter and Fiscal 2013 Financial Results
Business Wire - Tue Dec 10, 9:00AM CST
Nordion Inc. (TSX:NDN; NYSE:NDZ), a leading provider of products and services to the global health science market, today announced that the Company will report its fourth quarter and fiscal 2013 financial results before markets open on Thursday, January 9 , 2014.
Global Radiopharmaceutical Market 2012-2016: Increasing Demand for Radiopharmaceuticals is Expected to Fuel the Growth in this Market
M2 - Fri Nov 29, 6:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/ltk889/global) has announced the addition of the "Global Radiopharmaceutical Market 2012-2016" report to their offering. The analysts forecast the Global Radio Pharmaceutical market to grow at a CAGR of 18.39 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Radio Pharmaceutical market has also been witnessing the increasing demand for radiopharmaceuticals. However, the short half-life could pose a challenge to the growth of this market. The key vendors dominating this market space are Cardinal Health Inc., Covidien plc, Lantheus Medical Imaging Inc., and IBA Molecular Inc. Other vendors mentioned in the report are Advanced Medical Isotope Corp., Advanced Accelerator Applications SA, Algeta ASA, Bio-Nucleonics Inc., GE Healthcare Ltd., Monrol Nuclear Products Inc., Molecular Insight Pharmaceuticals Inc., Nordion Inc., Novelos Therapeutics Inc., NTP Radioisotopes (Pty) Ltd., Positron Corp., and Siemens Healthcare. Commenting on the report, an analyst from the team said: As a result of the rise in the incidences of cardiovascular, oncological, and neurological disorders among the population, there has been an increase in procedural volumes for PET, SPECT, SPECT-CT, PET-MRI, and SPECT-MRI procedures for imaging and diagnosis. Imaging without utilization of radiopharmaceuticals has become indispensable owing to their ability to enable diagnosis of various disease processes much earlier than other diagnostic test procedures. For instance, the increasing number of oncology and cardiology procedures is expected to drive the demand for radiopharmaceuticals such as fluorodeoxyglucose used for PET scans. Thus, increasing demand for radiopharmaceuticals is expected to fuel the growth in this market. According to the report, one of the main drivers in this market is the increasing aging population globally and the associated increase in incidences of cardiovascular diseases, neurological disorders, gastrointestinal diseases and oncological disorders among the aged population. The rise in demand for diagnostic screening of elderly patients has enhanced the need for radiopharmaceuticals. For more information visit http://www.researchandmarkets.com/research/ltk889/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
European Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market, 2017: Beta Emitters, Brachytherapy Isotopes & Alpha Emitters
M2 - Thu Nov 28, 9:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/dhw96m/european_nuclear) has announced the addition of the "European Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market, 2017" report to their offering. Segments in the therapeutic market are beta emitters, brachytherapy isotopes, and alpha emitters. Quantitative information about alpha emitters is not arrived at, as they have not been commercialized; recent clinical studies have, however, showcased immense potential of alpha isotopes in therapies. Beta emitters contribute the highest to the therapy market, dominated by Iodine-131(I-131), which is poised to grow at a CAGR of 3.9% from 2012 to 2017. European market is driven by its applications for thyroid cancer, hyperthyroidism, and non-Hodgkin's lymphoma. Significant isotopes in the brachytherapy market are Cesium-131 (Cs-131), Iodine-125 (I-125), Palladium-103 (Pd-103), and Iridium-192 (Ir-192). German is the major market for brachytherapy in terms of market share, followed by France. However, this market is showing slow growth due to reimbursement issues. Diagnostic - SPECT - PET Therapy - Beta emitters - Alpha emitters - Brachytherapy European Enriched Stable Isotopes Market - Deuterium - Oxygen-18 - Carbon-13 - Nitrogen-15 - Others Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 European Radiopharmaceuticals Market, By Isotope 5 European Radiopharmaceuticals Market,By Application/Indication 6 European Enriched Stable Isotopes Market 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles Companies Mentioned - Bracco Imaging SPA - Cambridge Isotope Laboratories, Inc - Cardinal Health, Inc - Covidien, Plc - Eczacibasi-Monrol - Fujifilm Holdings Corporation - GE Healthcare (Subsidiary Of General Electric Company) - IBA Group - Isotec, Inc (Sigma-Aldrich) - Lantheus Medical Imaging, Inc - NTP Radioisotopes (Pty), Ltd - Nordion, Inc - Petnet Solutions, Inc (A Subsidiary Of Siemens Medical Solutions USA, Inc) - Rotem Industries, Ltd, Inc - Taiyo Nippon Sanso Corporation - Urenco Limited Institutes Mentioned in the Report - Australian Nuclear Association And Technology Organization (ANSTO) - Institute Of Atomic Energy Polatom Radioisotope Centre - Institute Of Isotopes Co, Ltd - Institute Of Radioelement (IRE) For more information visit http://www.researchandmarkets.com/research/dh...an_nuclear About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Healthcare Companies Report Growth through FDA Approvals, Agreements and Announcements - Research Report on Johnson & Johnson, Stryker, Vertex, Fonar, and Nordion
PR Newswire - Thu Nov 28, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Johnson & Johnson (NYSE: JNJ), Stryker Corp. (NYSE: SYK), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Fonar Corp. (NASDAQ: FONR), and Nordion Inc. (NYSE: NDZ). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
NYSE stocks posting largest volume increases
AP - Mon Nov 25, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
Hill-Rom Elects William G. Dempsey to its Board of Directors
PR Newswire - Mon Mar 10, 7:00AM CDT
Hill-Rom Holdings, Inc. (NYSE: HRC) announced today that William G. Dempsey has been elected to its Board of Directors. He currently serves as a director of Landauer, Inc., Nordion Inc., and Hospira, Inc., and previously held various executive positions with Abbott Laboratories, including Executive Vice President of Global Pharmaceuticals, Senior Vice President of Pharmaceutical Operations, and Senior Vice President of International Operations. He also previously served as Chairman of the International Section of the Pharmaceutical Research and Manufacturers of America (PhRMA) and as Chairman of the Accelerating Access Initiative, a cooperative public-private partnership of UNAIDS, the World Bank, and six research-based pharmaceutical companies.
Nordion jumps up to GAAP net income of USD35.3m in Q1 fiscal 2014
M2 - Mon Mar 10, 5:00AM CDT
Health service company Nordion (TSX:NDN.TO) (NYSE:NDZ) announced on Friday its GAAP net income of USD35.3m for the first quarter of fiscal 2014.
Nordion Reports First Quarter Fiscal 2014 Financial Results
Business Wire - Fri Mar 07, 6:00AM CST
--GAAP earnings per share (EPS) of $0.57 in Q1 2014 versus $nil in Q1 2013. Non-GAAP adjusted EPS of $0.59 in Q1 2014, up from non-GAAP adjusted EPS of $0.05 in Q1 2013
Sterilization Equipment and Disinfectants Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
M2 - Fri Mar 07, 3:20AM CST
Research and Markets (http://www.researchandmarkets.com/research/z899cm/sterilization) has announced the addition of the "Sterilization Equipment and Disinfectants Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering 'Sterilization Equipment and Disinfectants Market (By Sterilization Equipment Type - Heat Sterilization, Low Temperature Sterilization, Filtration Sterilization and Radiation Sterilization,By Disinfectants Type-Low, Intermediate and High level and Oxidizing and Non-Oxidizing and By Applications- Medical Devices, Pharmaceuticals and Life-Sciences) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019' "Sterilization equipment and disinfectants are essential procedures for infection control in healthcare facilities such as hospitals, clinics and laboratories. Increase in hospital acquired infections has compelled medical professionals to take strict regulatory actions to cure these infections with the use of various sterilization equipment and disinfectants. This factor will trigger the growth of sterilization equipment and disinfectants market during the forecast period. In addition, rise in geriatric population and increase in the number of surgeries performed at hospitals and clinics will further drive the growth of this market. The market for sterilization equipment can be segmented as: by product (heat, low temperature, radiation and filtration sterilization) and by application (life sciences, medical devices and pharmaceuticals). The disinfectants market has been segmented based on types (low, intermediate and high level, oxidizing and non-oxidizing disinfectants). The report includes market estimations in terms of revenue (USD million) for the global sterilization equipment and disinfectants market for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for all the aforementioned segments and sub segments. In addition, current market trends and recent developments have been taken into consideration while determining the growth rate of the global sterilization equipment and disinfectants market. Key Topics Covered: Introduction Executive Summary Market Overview Global Sterilization Equipment Market, By Product, 2011 - 2019 (USD Million) Global Disinfectants Market, By Type, 2011 - 2019 (USD Million) Global Sterilization Equipment and Disinfectants Market, By Applications, 2011 - 2019 (USD Million) Global Sterilization Equipment and Disinfectants Market, by Geography, 2011 - 2019 (USD Million) Recommendations Company Profiles Companies Mentioned - 3M - Advanced Sterilization Products Services, Inc. - Belimed AG - Cantel Medical Corp. - CISA Group - Getinge Group - Kimberley-Clark Corporation - Matachana Group - Nordion, Inc. - SAKURA SI CO., LTD. - STERIS Corporation - Synergy Health Plc - TSO3, Inc. For more information visit http://www.researchandmarkets.com/research/z8...rilization About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Nordion Signs Two-Year Strontium-82 Supply Contract with Bracco Diagnostics
Business Wire - Tue Mar 04, 7:01AM CST
Nordion Inc. (TSX:NDN) (NYSE:NDZ) announced today that it has entered into a two-year contract with Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a global leading company in the diagnostic imaging business, to supply strontium-82, a cyclotron based medical isotope produced both at Nordion's Vancouver, British Columbia and Ottawa, Ontario facilities.
Nordion to Release First Quarter Fiscal 2014 Financial Results
Business Wire - Fri Feb 28, 11:00AM CST
Nordion Inc. (TSX:NDN; NYSE:NDZ), a leading provider of products and services to the global health science market, today announced that the Company is scheduled to report its first quarter fiscal 2014 financial results before markets open on March 7, 2014.
North American Radiopharmaceuticals Market is Poised to Reach $2.7 Billion By 2017 at a CAGR of 7.2%
M2 - Wed Feb 26, 10:00AM CST
Research and Markets (http://www.researchandmarkets.com/research/5r3ppz/north_american) has announced the addition of the "North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market [SPECT/PET Radioisotopes (Technetium, F-18)], [Beta/Alpha Radiation Therapy (I131, Y-90)], [Applications (Cancer/Oncology, Cardiac)] & (Deuterium, C-13) - Forecast to 2017" report to their offering. A study conducted by Organization for Economic Co-operation and Development (OECD) estimates that Tc-99m diagnostic procedures are expected to increase by 15% to 20% in mature markets such as North America between 2010 and 2030. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinson's disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications. The scheduled shutdown of the NRU reactor in 2016 in Canada is, however, a major threat for manufacturers. The U.S. is the dominant market for diagnostic radioisotopes with more than 80% share. The U.S. is the largest consumer market for radiopharmaceuticals in North America, while Canada is one of the largest producers of Tc-99m. Major players in the radiopharmaceuticals market are Cardinal Health, Inc. (U.S.), Lantheus Medical Imaging, Inc. (U.S.), Nordion, Inc. (Canada), and Triad Isotopes, Inc. (U.S.). The stable isotopes market was led by two players - Cambridge Isotope Laboratories (CIL) and Sigma Aldrich - in 2012; they jointly contributed more than 90% to the North American revenue. Companies Mentioned: - Australian Nuclear Association And Technology Organization (Ansto) - Board Of Radiation And Isotope Technology (Brit) - Bracco Imaging S.P.A. - Cambridge Isotope Laboratories, Inc. - Cardinal Health, Inc. - Covidien, Plc - Eczacibasi-Monrol - Fujifilm Holdings Corporation - Ge Healthcare (Subsidiary Of General Electric Company) - Iba Group - Institute Of Atomic Energy Polatom Radioisotope Centre - Institute Of Isotopes Co., Ltd. - Institute Of Radioelement (Ire) - Isotec, Inc. (Sigma-Aldrich) - Lantheus Medical Imaging, Inc. - Nordion, Inc. - Ntp Radioisotopes (Pty), Ltd. - Petnet Solutions, Inc. (A Subsidiary Of Siemens Medical Solutions Usa, Inc.) - Rotem Industries, Ltd., Inc. - Taiyo Nippon Sanso Corporation - Triad Isotopes, Inc. - Urenco Limited For more information visit http://www.researchandmarkets.com/research/5r...h_american About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Global Rubber Market 2014-2018 with Styron LLC, Thai Rubber Latex Corp., and The DOW Chemical Co. Dominating
M2 - Wed Feb 19, 11:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/938d94/global_rubber) has announced the addition of the "Global Rubber Market 2014-2018" report to their offering. The analysts forecast the Global Rubber market to grow at a CAGR of 5.89 percent and 6.36 percent on the basis of production and consumption, respectively, over the period 2013-2018. One of the key factors contributing to this market growth is the increasing demand for disposable medical gloves. The Global Rubber market has also been witnessing the increasing demand for synthetic rubber from the emerging economies. However, the increasing demand of natural disasters and adverse weather conditions could pose a challenge to the growth of this market. Key vendors dominating this space are BASF SE, Styron LLC, Thai Rubber Latex Corp., and The DOW Chemical Co. Other vendors mentioned in the report are Advance Multitech Ltd., Advance Petrochemical Ltd., Ansell Ltd., Asahi Kasei Corp., Bando Chemical Industries Ltd., Bridgestone Corp., Behn Meyer Group, China National Petroleum Corp., Convex Latex Pvt. Ltd., HLL Lifecare Ltd., Hwafong Rubber Thailand Public Co. Ltd., Lanxess AG, LG Chem Ltd., Nishikawa Rubber Co. Ltd., Nordion Inc., RFB Rubber Ltd., Shun Thai Rubber Gloves Industry Public Co. Ltd., Sinopec Ltd., Sumitomo Chemical Co. Ltd., St. Marys Rubbers Pvt. Ltd., Synthos S.A., Textile Rubber & Chemical Co. Inc., Tianjin Lugang Petroleum Rubber Co. Ltd., Versalis S.p.A, and Wacker Chemie AG. Commenting on the report, an analyst from the team said: The demand for synthetic rubber is estimated to increase at a steady pace in the future due to the growing demand from emerging economies. The APAC region is the largest synthetic rubber consumer, with China being the leader in synthetic rubber production and consumption. The rubber market in the APAC region is expected to grow at a rapid pace during the forecast period. It is expected to account for more than 50 percent of the production and consumption of synthetic rubber with the increasing demand for synthetic rubber in the Automobile sector, and the Construction and Tire industries. For more information visit http://www.researchandmarkets.com/research/93...bal_rubber About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Concise Analysis of the International Radiopharmaceuticals Market
M2 - Fri Feb 14, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/5ltj8g/radiopharmaceutica) has announced the addition of the "Concise Analysis of the International Radiopharmaceuticals Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: - Diagnostic Radiopharmaceuticals - Therapeutic Radiopharmaceuticals. The report profiles 69 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc. - Advanced Medical Isotope Corporation - Alseres Pharmaceuticals Inc. - Bayer HealthCare Pharmaceuticals - Bracco Diagnostics Inc. - Cardinal Health Inc. - Covidien Plc - Eli Lilly and Company - Erigal Limited - EUSA Pharma (Europe) Ltd. - GE Healthcare - IBA Group - Immunomedics Inc. - Jubilant Life Sciences Limited - Lantheus Medical Imaging Inc. - Medi-Radiopharma Ltd. - Nordion Inc. - Peregrine Pharmaceuticals Inc. - PETNET Solutions Inc. - Positron Corporation - Singapore Radiopharmaceuticals Pte Ltd. - Triad Isotopes Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers & Trends 3. Market Challenges 4. Therapeutic Radiopharmaceutical Products Under Development 5. Imaging Agents - An Overview 6. Nuclear Medicine - An Overview 7. Product Overview 8. Product Innovations/Introductions 9. Product Innovations/Introductions In Recent Past- A Perspective Builder 10. Recent Industry Activity 11. Corporate Activity In The Recent Past - A Perspective Builder 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79) - The United States (36) - Canada (2) - Japan (1) - Europe (28) - France (2) - Germany (2) - The United Kingdom (4) - Italy (2) - Spain (1) - Rest of Europe (17) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/5l...rmaceutica
2014 Report on the European Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017
M2 - Mon Jan 27, 4:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/gchtqj/european_nuclear) has announced the addition of the "2014 Report on the European Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017" report to their offering. The therapy market is predominantly driven by its oncologic applications. Since conventional treatment procedures of cancer, surgery and chemotherapy have significant side effects, radioisotopes are being preferred by medical practitioners due to minimum or no side effects. The radiopharmaceutical therapy market is expected to grow significantly with the launch of the much-desired Alpharadin (Ra-223) in the near future. This isotope has tremendous potential to take up market share of beta emitters and brachytherapy. Germany accounted for the largest market share of the European nuclear medicine market, followed by France in 2012. Major players in the radiopharmaceuticals market are Covidien, Plc, GE Healthcare, IBA Group, Lantheus Medical Imaging, Inc., Nordion, Inc., and Siemens Healthcare (PETNET). The stable isotopes market is dominated by deuterium (D2), oxygen-18 (O-18), carbon-13 (C-13), and nitrogen-15 (N-15). It has major applications in research, pharmaceuticals, diagnostic and therapy, and the industrial sector. The diagnostic and therapy market accounted for the maximum share of the stable isotopes market. The European stable isotopes market was valued at close to $25.0 million in 2012, and is estimated to grow at a CAGR of more than 8.0% by 2017. The stable isotopes market was led by two players - Cambridge Isotope Laboratories (CIL) and Sigma Aldrich - in 2012; they jointly contributed more than 50% to the European revenue. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 European Radiopharmaceuticals Market, By Isotope 5 European Radiopharmaceuticals Market,By Application/Indication 6 European Enriched Stable Isotopes Market 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles Companies Mentioned: - Bracco Imaging - Cambridge Isotope Laboratories - Cardinal Health - Covidien - Eczacibasi-Monrol - Fujifilm Holdings - GE Healthcare - IBA Group - Isotec - Lantheus Medical Imaging - NTP Radioisotopes - Nordion, Inc - Petnet Solutions - Rotem Industries - Taiyo Nippon Sanso - Urenco For more information visit http://www.researchandmarkets.com/research/gc...an_nuclear
Why Macy's, Nordion, and Acuity Brands Soared Today
Dan Caplinger, The Motley Fool - Motley Fool - Thu Jan 09, 7:01PM CST
Although we don't believe in timing the market or panicking over daily movements, we do like to keep an eye on market changes -- just in case they're material to our investing thesis. The stock market fought mostly to a draw on Thursday, with...
NYSE stocks posting largest percentage increases
AP - Thu Jan 09, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on New York Stock Exchange at the close of trading:
Nordion Reports Fourth Quarter and Fiscal 2013 Financial Results; Provides Fiscal 2014 Outlook
Business Wire - Thu Jan 09, 5:59AM CST
--GAAP earnings per share (EPS) of $0.91 in Q4 2013 versus $0.70 loss per share (LPS) in Q4 2012. Adjusted EPS, excluding specified items, of $0.15 in Q4 2013, down from adjusted EPS of $0.27 in Q4 2012
2013 Report on the North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017
M2 - Mon Dec 23, 3:59AM CST
Research and Markets (http://www.researchandmarkets.com/research/gn9bsn/north_american) has announced the addition of the "2013 Report on the North American Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market - Forecast to 2017" report to their offering. Radiopharmaceuticals in neurological applications such as Alzheimer's disease, Parkinson's disease, and dementia are also being preferred by practitioners besides conventional treatment. Further, upcoming radioisotopes such as Ra-223 (Alpharadin) and Ga-68 possess huge potential for clinical applications. The scheduled shutdown of the NRU reactor in 2016 in Canada is, however, a major threat for manufacturers. The therapy market is predominantly driven by its oncologic applications. Since conventional treatment procedures of cancer, surgery and chemotherapy have significant side effects; radioisotopes are being preferred by medical practitioners due to minimum or no side effects. The radiopharmaceutical therapy market is expected to grow significantly with the launch of the much-desired Alpharadin (Ra-223) in the near future. This isotope has tremendous potential to take up market share of beta emitters and brachytherapy. Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 North American Radiopharmaceuticals Market, By Isotope 5 North American Radiopharmaceuticals Market, By Application/Indications 6 North American Enriched Stable Isotopes Market 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles Companies Mentioned: - Australian Nuclear Association And Technology Organization (Ansto) - Board Of Radiation And Isotope Technology (Brit) - Bracco Imaging S.P.A. - Cambridge Isotope Laboratories, Inc. - Cardinal Health, Inc. - Covidien, Plc - Eczacibasi-Monrol - Fujifilm Holdings Corporation - Ge Healthcare (Subsidiary Of General Electric Company) - Iba Group - Institute Of Atomic Energy Polatom Radioisotope Centre - Institute Of Isotopes Co., Ltd. - Institute Of Radioelement (Ire) - Isotec, Inc. (Sigma-Aldrich) - Lantheus Medical Imaging, Inc. - Nordion, Inc. - Ntp Radioisotopes (Pty), Ltd. - Petnet Solutions, Inc. (A Subsidiary Of Siemens Medical Solutions Usa, Inc.) - Rotem Industries, Ltd., Inc. - Taiyo Nippon Sanso Corporation - Triad Isotopes, Inc. - Urenco Limited For more information visit http://www.researchandmarkets.com/research/gn...h_american
Nordion to Release Fourth Quarter and Fiscal 2013 Financial Results
Business Wire - Tue Dec 10, 9:00AM CST
Nordion Inc. (TSX:NDN; NYSE:NDZ), a leading provider of products and services to the global health science market, today announced that the Company will report its fourth quarter and fiscal 2013 financial results before markets open on Thursday, January 9 , 2014.
Global Radiopharmaceutical Market 2012-2016: Increasing Demand for Radiopharmaceuticals is Expected to Fuel the Growth in this Market
M2 - Fri Nov 29, 6:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/ltk889/global) has announced the addition of the "Global Radiopharmaceutical Market 2012-2016" report to their offering. The analysts forecast the Global Radio Pharmaceutical market to grow at a CAGR of 18.39 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Radio Pharmaceutical market has also been witnessing the increasing demand for radiopharmaceuticals. However, the short half-life could pose a challenge to the growth of this market. The key vendors dominating this market space are Cardinal Health Inc., Covidien plc, Lantheus Medical Imaging Inc., and IBA Molecular Inc. Other vendors mentioned in the report are Advanced Medical Isotope Corp., Advanced Accelerator Applications SA, Algeta ASA, Bio-Nucleonics Inc., GE Healthcare Ltd., Monrol Nuclear Products Inc., Molecular Insight Pharmaceuticals Inc., Nordion Inc., Novelos Therapeutics Inc., NTP Radioisotopes (Pty) Ltd., Positron Corp., and Siemens Healthcare. Commenting on the report, an analyst from the team said: As a result of the rise in the incidences of cardiovascular, oncological, and neurological disorders among the population, there has been an increase in procedural volumes for PET, SPECT, SPECT-CT, PET-MRI, and SPECT-MRI procedures for imaging and diagnosis. Imaging without utilization of radiopharmaceuticals has become indispensable owing to their ability to enable diagnosis of various disease processes much earlier than other diagnostic test procedures. For instance, the increasing number of oncology and cardiology procedures is expected to drive the demand for radiopharmaceuticals such as fluorodeoxyglucose used for PET scans. Thus, increasing demand for radiopharmaceuticals is expected to fuel the growth in this market. According to the report, one of the main drivers in this market is the increasing aging population globally and the associated increase in incidences of cardiovascular diseases, neurological disorders, gastrointestinal diseases and oncological disorders among the aged population. The rise in demand for diagnostic screening of elderly patients has enhanced the need for radiopharmaceuticals. For more information visit http://www.researchandmarkets.com/research/ltk889/global About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
European Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market, 2017: Beta Emitters, Brachytherapy Isotopes & Alpha Emitters
M2 - Thu Nov 28, 9:36AM CST
Research and Markets (http://www.researchandmarkets.com/research/dhw96m/european_nuclear) has announced the addition of the "European Nuclear Medicine/Radiopharmaceuticals & Stable Isotopes Market, 2017" report to their offering. Segments in the therapeutic market are beta emitters, brachytherapy isotopes, and alpha emitters. Quantitative information about alpha emitters is not arrived at, as they have not been commercialized; recent clinical studies have, however, showcased immense potential of alpha isotopes in therapies. Beta emitters contribute the highest to the therapy market, dominated by Iodine-131(I-131), which is poised to grow at a CAGR of 3.9% from 2012 to 2017. European market is driven by its applications for thyroid cancer, hyperthyroidism, and non-Hodgkin's lymphoma. Significant isotopes in the brachytherapy market are Cesium-131 (Cs-131), Iodine-125 (I-125), Palladium-103 (Pd-103), and Iridium-192 (Ir-192). German is the major market for brachytherapy in terms of market share, followed by France. However, this market is showing slow growth due to reimbursement issues. Diagnostic - SPECT - PET Therapy - Beta emitters - Alpha emitters - Brachytherapy European Enriched Stable Isotopes Market - Deuterium - Oxygen-18 - Carbon-13 - Nitrogen-15 - Others Key Topics Covered: 1 Introduction 2 Executive Summary 3 Market Overview 4 European Radiopharmaceuticals Market, By Isotope 5 European Radiopharmaceuticals Market,By Application/Indication 6 European Enriched Stable Isotopes Market 7 Geographic Analysis 8 Competitive Landscape 9 Company Profiles Companies Mentioned - Bracco Imaging SPA - Cambridge Isotope Laboratories, Inc - Cardinal Health, Inc - Covidien, Plc - Eczacibasi-Monrol - Fujifilm Holdings Corporation - GE Healthcare (Subsidiary Of General Electric Company) - IBA Group - Isotec, Inc (Sigma-Aldrich) - Lantheus Medical Imaging, Inc - NTP Radioisotopes (Pty), Ltd - Nordion, Inc - Petnet Solutions, Inc (A Subsidiary Of Siemens Medical Solutions USA, Inc) - Rotem Industries, Ltd, Inc - Taiyo Nippon Sanso Corporation - Urenco Limited Institutes Mentioned in the Report - Australian Nuclear Association And Technology Organization (ANSTO) - Institute Of Atomic Energy Polatom Radioisotope Centre - Institute Of Isotopes Co, Ltd - Institute Of Radioelement (IRE) For more information visit http://www.researchandmarkets.com/research/dh...an_nuclear About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Healthcare Companies Report Growth through FDA Approvals, Agreements and Announcements - Research Report on Johnson & Johnson, Stryker, Vertex, Fonar, and Nordion
PR Newswire - Thu Nov 28, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting Johnson & Johnson (NYSE: JNJ), Stryker Corp. (NYSE: SYK), Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), Fonar Corp. (NASDAQ: FONR), and Nordion Inc. (NYSE: NDZ). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
NYSE stocks posting largest volume increases
AP - Mon Nov 25, 5:04PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:
(0)
(0)Nordion Inc. (NDZ) Stock Research Links
Scroll down for more posts ▼